How does liraglutide differ from semaglutide?

Liraglutide in Canada

What liraglutide costs in Canada, which licensed clinics prescribe it, and what the evidence actually supports.

Updated: July 28, 2026

Last reviewed: July 27, 2026 · Editorial team · Canadian availability verified per province

Editorial testing in progress

We have not finished verifying Canadian liraglutide providers against real provincial availability, and we would rather publish nothing than publish rankings we have not checked. In the meantime, our published categories below are live.

GLP-1 Weight Loss Semaglutide

Prescription notice

GLP-1 medications, finasteride, NAD+ injections and the other treatments compared on this site are prescription-only in Canada. A prescription is issued only when a clinician licensed in your province determines it is clinically appropriate for you. Approval is never guaranteed.

Explore More Treatments

Best GLP-1 Weight Loss in Canada

Health Canada-authorized GLP-1 weight loss programs from licensed Canadian telehealth clinics, compared on all-in monthly cost.

Best Semaglutide in Canada

Semaglutide in Canada — generic, Ozempic and Wegovy — from licensed Canadian telehealth clinics, compared on all-in monthly cost.

Liraglutide Availability by Province

Telehealth is regulated provincially in Canada. Confirm your province is served before paying a consultation fee.

Ontario British Columbia Alberta Quebec Manitoba Saskatchewan Nova Scotia New Brunswick Prince Edward Island Newfoundland and Labrador

Frequently Asked Questions

Liraglutide is injected daily; semaglutide is injected weekly. Both are GLP-1 receptor agonists, but the weekly schedule and the trial results for semaglutide have made it the more commonly prescribed option for weight management. Liraglutide remains authorised and is sometimes preferred where a shorter-acting agent suits the clinical picture.

References and further reading

Health Canada, Drug Product Database (Health Canada). Whether a specific drug product is authorized for sale in Canada.
Obesity Canada and CMAJ, 2025 pharmacotherapy guideline (CMAJ / Obesity Canada). Canadian obesity guideline on long-term weight-management medicine.

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.